Skip to main content
. 2021 Dec 10;10(24):e023535. doi: 10.1161/JAHA.121.023535

Figure 3. Weighted Kaplan‐Meier curve comparing survival by in‐hospital ACEi/ARB use.

Figure 3

Weighted Kaplan‐Meier curve depicting survival probabilities of combined outcome of death, need for mechanical ventilation, or dialysis by in‐hospital ACEi/ARB over 30 days of hospitalization. Based on marginal structural model with weights accounting for age, sex, race, BMI, diabetes, hypertension, coronary artery disease, congestive heart failure, and serial measurements of blood pressure and serum creatinine. ACEi/ARB indicates angiotensin‐converting enzyme inhibitor/angiotensin receptor blocker; and BMI, body mass index.